Paid extends forbearance on $5.97M Embolx note to Oct 31, 2026
Paid says a letter dated Aug 31, 2026 extends forbearance on its $5.97 million Embolx note through Oct 31, 2026, following prior amendments and earlier financing actions tied to its Embolx investment.
Paid detailed a series of financing actions related to its investment in Embolx, culminating in a letter dated Aug 31, 2026 that extends forbearance through Oct 31, 2026.
The relationship began with a secured $1.875 million convertible note in Oct 2022 and was restructured in Mar 2024 with an added…